Postpartum Low-Dose Esketamine Aids Moms With Prenatal Depression
Single low-dose esketamine reduces depressive episodes at 42 days postpartum for mothers with prenatal depression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.